Immunotherapy for murine K1735 melanoma: Combinatorial use of recombinant adenovirus expressing CD40L and other immunomodulators

Cancer Gene Therapy

Volumn 9, Issue 7, 2002, Pages 597-605

  Peter, Isabelle ^a   Nawrath, Michael ^a   Kamarashev, Jivko ^b   Odermatt, Bernhard ^b   Mezzacasa, Anna ^a   Hemmi, Silvio ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Adenovirus; CD40L; Cytokines; Immunotherapy; K1735; Melanoma

Indexed keywords

B7 ANTIGEN; CD40 LIGAND; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IMMUNOMODULATING AGENT; INTERLEUKIN 12; INTERLEUKIN 2; DNA VACCINE;

ADENOVIRUS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER SURVIVAL; CARCINOGENICITY; CONTROLLED STUDY; CYTOMEGALOVIRUS; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; FEMALE; GRANULOCYTE; HUMAN; HUMAN CELL; IMMUNITY; IMMUNOTHERAPY; MACROPHAGE; MELANOMA; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; VACCINATION; VIRUS RECOMBINANT; ANIMAL; C3H MOUSE; CANCER TRANSPLANTATION; CELL CULTURE; DISEASE FREE SURVIVAL; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GENE THERAPY; GENETICS; IMMUNOHISTOCHEMISTRY; METABOLISM; METHODOLOGY; TIME;

ADENOVIRIDAE; ANIMAL; CD40 LIGAND; DISEASE-FREE SURVIVAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; GENE THERAPY; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; GRANULOCYTES; IMMUNOHISTOCHEMISTRY; IMMUNOTHERAPY; INTERLEUKIN-2; KILLER CELLS, NATURAL; MACROPHAGES; MELANOMA; MICE; MICE, INBRED C3H; NEOPLASM TRANSPLANTATION; SUPPORT, NON-U.S. GOV'T; TIME FACTORS; TUMOR CELLS, CULTURED; VACCINES, DNA; ANIMALS;

EID: 0036019376     PISSN: 09291903     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.cgt.7700475     Document Type: Article

References (32)

1. Cancer statistics, 1998
2. Tumor antigens recognized by T lymphocytes
3. Tumor rejection after direct costimulation of CD8+ T cells by B7-transfected melanoma cells
4. Interleukin-2 production by tumor cells bypasses T helper function in the generation of an antitumor response
5. Fibroblasts genetically engineered to secrete interleukin 12 can suppress tumor growth and induce antitumor immunity to a murine melanoma in vivo
6. Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity
7. Vaccination with irradiated autologous melanoma cells engineered to secrete human granulocyte-macrophage colony-stimulating factor generates potent antitumor immunity in patients with metastatic melanoma
8. Costimulation of antitumor immunity by the B7 counterreceptor for the T lymphocyte molecules CD28 and CTLA-4
9. Immunological gene therapy with ex vivo gene-modified tumor cells: A critique and a reappraisal
10. Dendritic cells and the control of immunity
11. CD40 ligand induces an antileukemia immune response in vivo
12. Antitumor effect of CD40 ligand: Elicitation of local and systemic antitumor responses by IL-12 and B7
13. Antitumor responses induced by transgenic expression of CD40 ligand
14. Anti-tumor immunity induced by in vivo adenovirus vector-mediated expression of CD40 ligand in tumor cells
15. In vivo gene transfer of CD40 ligand into colon cancer cells induces local production of cytokines and chemokines, tumor eradication and protective antitumor immunity
16. Thelper- and accessory-cell-independent cytotoxic responses to human tumor cells transfected with a B7 retroviral vector
17. Adenovirus-mediated gene transfer into monocyte-derived macrophages of patients with X-linked chronic granulomatous disease: Ex vivo correction of deficient respiratory burst
18. The polypeptides of adenovirus. I. Evidence for multiple protein components in the virion and a comparison of types 2, 7A, and 12
19. Cloning and expression of murine IL-12
20. Therapy of tuberculosis in mice by DNA vaccination
21. Cancer vaccines: The interleukin 2 dosage effect
22. Activation of human dendritic cells through CD40 cross-linking
23. Inhibition of murine melanoma growth by granulocyte-macrophage colony stimulating factor gene transfection is not haplotype specific
24. Biology of adenovirus vectors with E1 and E4 deletions for liver-directed gene therapy
25. Comparative analysis of immunocritical melanoma markers in the mouse melanoma cell lines B16, K1735 and S91-M3
26. Gene transfer of GM-CSF, CD80 and CD154 cDNA enhances survival in a murine model of acute leukemia with persistence of a minimal residual disease
27. Therapeutic vaccination for cancer
28. GM-CSF and TNF-alpha cooperate in the generation of dendritic Langerhans cells
29. Phase I study of recombinant human CD40 ligand in cancer patients
30. Inhibition of human B-cell lymphoma growth by CD40 stimulation
31. Expression of costimulatory molecules by tumor cells decreases tumorigenicity but may also reduce systemic antitumor immunity
32. Cytokine gene transfer in tumor inhibition and tumor therapy: Where are we now?